litlas
ログインアカウント作成

Satoru Todo

1979–2018 年に発表

113
論文数
19,328
被引用数
88
h 指数
113
i10 指数

被引用数

Satoru Todo の年別被引用数1987 年: 被引用 12 件1988 年: 被引用 31 件1989 年: 被引用 40 件1990 年: 被引用 57 件1991 年: 被引用 102 件1992 年: 被引用 76 件1993 年: 被引用 89 件1994 年: 被引用 89 件1995 年: 被引用 105 件1996 年: 被引用 121 件1997 年: 被引用 96 件1998 年: 被引用 102 件1999 年: 被引用 125 件2000 年: 被引用 137 件2001 年: 被引用 132 件2002 年: 被引用 127 件2003 年: 被引用 116 件2004 年: 被引用 102 件2005 年: 被引用 107 件2006 年: 被引用 122 件2007 年: 被引用 95 件2008 年: 被引用 114 件2009 年: 被引用 136 件2010 年: 被引用 108 件2011 年: 被引用 85 件2012 年: 被引用 94 件2013 年: 被引用 89 件2014 年: 被引用 78 件2015 年: 被引用 82 件2016 年: 被引用 65 件2017 年: 被引用 54 件2018 年: 被引用 42 件2019 年: 被引用 209 件2020 年: 被引用 213 件2021 年: 被引用 201 件2022 年: 被引用 114 件2023 年: 被引用 101 件2024 年: 被引用 124 件2025 年: 被引用 48 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,441 件、この内訳の 32.7%中国: 引用元論文 381 件、この内訳の 8.6%日本: 引用元論文 359 件、この内訳の 8.2%イギリス: 引用元論文 298 件、この内訳の 6.8%ドイツ: 引用元論文 231 件、この内訳の 5.2%フランス: 引用元論文 199 件、この内訳の 4.5%イタリア: 引用元論文 195 件、この内訳の 4.4%カナダ: 引用元論文 131 件、この内訳の 3%スペイン: 引用元論文 126 件、この内訳の 2.9%オランダ: 引用元論文 111 件、この内訳の 2.5%オーストラリア: 引用元論文 93 件、この内訳の 2.1%韓国: 引用元論文 82 件、この内訳の 1.9%
0%32.7%その他 17.2%

機関

分野

  • Medicine71.4%
  • Biochemistry, Genetics and Molecular Biology11.6%
  • Immunology and Microbiology8.9%
  • Nursing2.6%
  • Neuroscience1.6%
  • Pharmacology, Toxicology and Pharmaceutics1.3%
  • その他2.6%

トピック

  • Organ Transplantation Techniques and Outcomes10.3%
  • Liver Disease and Transplantation7.2%
  • Hepatocellular Carcinoma Treatment and Prognosis5%
  • Renal Transplantation Outcomes and Treatments4.2%
  • Liver Disease Diagnosis and Treatment3.8%
  • Cholangiocarcinoma and Gallbladder Cancer Studies3.2%
  • その他66.3%

共著者

全論文

検索で開く
  1. A pilot study of operational tolerance with a regulatory T‐cell‐based cell therapy in living donor liver transplantation

    著者: Satoru Todo, Kenichiro Yamashita, Ryoichi Goto, Masaaki Zaitsu, Akihisa Nagatsu, Tetsu Oura, Masaaki Watanabe, Takeshi Aoyagi, Tomomi Suzuki, Tsuyoshi Shimamura, Toshiya Kamiyama, Norihiro Sato, Junichi Sugita, Kanako C. Hatanaka, Hisashi Bashuda, Sonoko Habu, Anthony J. Demetris, Ko Okumura - Hepatology 2016 被引用: 433

  2. Expanded living‐donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5‐5‐500 rule ‐ a retrospective study

    著者: Tsuyoshi Shimamura, Nobuhisa Akamatsu, Masato Fujiyoshi, Atsushi Kawaguchi, Satoshi Morita, Seiji Kawasaki, Shinji Üemoto, Norihiro Kokudo, Kiyoshi Hasegawa, Hideki Ohdan, Hiroto Egawa, Hiroyuki Furukawa, Satoru Todo, the Japanese Liver Transplantation Society - Transplant International 2018 被引用: 152

  3. FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION

    著者: ThomasE. Starzl, John J. Fung, Raman Venkataramman, Satoru Todo, AnthonyJ. Demetris, Ashok Jain - The Lancet 1989 被引用: 1,054

  4. The Novel Antioxidant Edaravone: From Bench to Bedside

    著者: Toshiaki Watanabe, Munenori Tahara, Satoru Todo - Cardiovascular Therapeutics 2008 被引用: 226

  5. TRIM40 promotes neddylation of IKK and is downregulated in gastrointestinal cancers

    著者: Kazuto Noguchi, Fumihiko Okumura, Naoko Takahashi, Akihiko Kataoka, Toshiya Kamiyama, Satoru Todo, Shigetsugu Hatakeyama - Carcinogenesis 2011 被引用: 120

  6. Alveolar Echinococcosis: MR Findings in the Liver

    著者: Yoshihisa Kodama, Nobuyuki Fujita, Tadashi Shimizu, Hideho Endo, Toshikazu Nambu, Naoki Sato, Satoru Todo, K Miyasaka - Radiology 2003 被引用: 188

  7. Co-Expression of Mesothelin and CA125 Correlates With Unfavorable Patient Outcome in Pancreatic Ductal Adenocarcinoma

    著者: Takahiro Einama, Hirofumi Kamachi, Hiroshi Nishihara, Shigenori Homma, Hiromi Kanno, Kenta Takahashi, Ayami Sasaki, Munenori Tahara, Kuniaki Okada, Shunji Muraoka, Toshiya Kamiyama, Yoshihiro Matsuno, Michitaka Ozaki, Satoru Todo - Pancreas 2011 被引用: 110

  8. Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer

    著者: Takahiro Einama, Shigenori Homma, Hirofumi Kamachi, Futoshi Kawamata, Kohei Takahashi, Norihiko Takahashi, Masahiko Taniguchi, Toshiya Kamiyama, H. Furukawa, Yoshihiro Matsuno, Shinya Tanaka, Hiroshi Nishihara, Akinobu Taketomi, Satoru Todo - British Journal of Cancer 2012 被引用: 88

  9. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma

    著者: Kazuaki Nakanishi, Michiie Sakamoto, Susumu Yamasaki, Satoru Todo, Setsuo Hirohashi - Cancer 2004 被引用: 224

  10. Neurologic complications of FK 506.

    著者: Benjamin H. Eidelman, Kareem Abu‐Elmagd, John Wilson, John J. Fung, M Alessiani, Ashokkumar Jain, S Takaya, Satoru Todo, Andreas G. Tzakis, David Van Thiel - 1991 被引用: 185

  11. Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer–Initiating Cells and Is a Potent Target of Immunotherapy

    著者: Rena Morita, Yoshihiko Hirohashi, Toshihiko Torigoe, Satoko Ito-Inoda, Akari Takahashi, Tasuku Mariya, Hiroko Asanuma, Yasuaki Tamura, Tomohide Tsukahara, Takayuki Kanaseki, Terufumi Kubo, Goro Kutomi, Toru Mizuguchi, Takeshi Terui, Kunihiko Ishitani, Satoshi Hashino, Tôru Kondo, Nozomi Minagawa, Norihiko Takahashi, Akinobu Taketomi, Satoru Todo, Masahiro Asaka, Noriyuki Sato - Clinical Cancer Research 2016 被引用: 86

  12. Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance

    著者: Thomas E. Starzl, Anthony J. Demetris, Massimo Trucco, Noriko Murase, Camillo Ricordi, Suzanne T. Ildstad, Hector C. Ramos, Satoru Todo, Andreas Tzakis, John J. Fung, Michael A. Nalesnik, Adriana Zeevi, William A. Rudert, Mirjana Kočova - Hepatology 1993 被引用: 811

  13. Baboon-to-human liver transplantation

    著者: Thomas E. Starzl, John J. Fung, Andreas G. Tzakis, Satoru Todo, Anthony J. Demetris, Ignazio R. Marino, H. Doyle, Adriana Zeevi, Vijay Warty, Shimon Kusne, Anthony J. Demetris, Adriana Zeevi, Vijay Warty, William A. Rudert, Massimo Trucco, Marian G. Michaels, Shimon Kusne, William A. Rudert, Massimo Trucco - The Lancet 1993 被引用: 469

  14. Perioperative Management of Hepatic Resection Toward Zero Mortality and Morbidity: Analysis of 793 Consecutive Cases in a Single Institution

    著者: Toshiya Kamiyama, Kazuaki Nakanishi, Hideki Yokoo, Hirofumi Kamachi, Munenori Tahara, Kenichiro Yamashita, Masahiko Taniguchi, Tsuyoshi Shimamura, Michiaki Matsushita, Satoru Todo - Journal of the American College of Surgeons 2010 被引用: 188

  15. Macrophage Migration Inhibitory Factor (MIF)

    著者: Jun Nishihira, Teruo Ishibashi, Tsuyoshi Fukushima, Bailong Sun, Yuji Sato, Satoru Todo - Annals of the New York Academy of Sciences 2003 被引用: 140

  16. Markers for microvascular invasion in hepatocellular carcinoma: Where do we stand?

    著者: Annette S.H. Gouw, Charles Balabaud, Hironori Kusano, Satoru Todo, Takafumi Ichida, Masamichi Kojiro - Liver Transplantation 2011 被引用: 112

  17. Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice

    著者: Sanae Haga, Wataru Ogawa, Hiroshi Inoue, Keita Terui, Tetsuya Ogino, Rumi Igarashi, Kiyoshi Takeda, Shizuo Akira, Shin Enosawa, Hiroyuki Furukawa, Satoru Todo, Michitaka Ozaki - Journal of Hepatology 2005 被引用: 107

  18. Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis

    著者: Toshiya Kamiyama, Hideki Yokoo, Jun‐ichi Furukawa, Masaki Kurogochi, Tomoaki Togashi, Nobuaki Miura, Kazuaki Nakanishi, Hirofumi Kamachi, Tatsuhiko Kakisaka, Yosuke Tsuruga, Masato Fujiyoshi, Akinobu Taketomi, Shin‐Ichiro Nishimura, Satoru Todo - Hepatology 2013 被引用: 90

  19. Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma

    著者: Shohei Honda, Yasuhito Arai, Masayuki Haruta, F Sasaki, Miki Ohira, Hiroaki Yamaoka, Hiroshi Horie, Akira Nakagawara, Eiso Hiyama, Satoru Todo, Yasuhiko Kaneko - British Journal of Cancer 2008 被引用: 90

  20. Orthotopic Liver Transplantation with Preservation of the Inferior Vena Cava

    著者: Andreas G. Tzakis, Satoru Todo, Thomas E. Starzl - Annals of Surgery 1989 被引用: 638

  21. Phase II Study of Docetaxel and S-1 Combination Therapy for Advanced or Recurrent Gastric Cancer

    著者: Kazuhiro Yoshida, Motoki Ninomiya, Norihisa Takakura, Naoki Hirabayashi, Wataru Takiyama, Yuji Sato, Satoru Todo, Masanori Terashima, Mitsukazu Gotoh, Jyunnichi Sakamoto, Masahiko Nishiyama - Clinical Cancer Research 2006 被引用: 172

  22. Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506.

    著者: Noriko Murase, Anthony J. Demetris, Tsuyoshi Matsuzaki, A Yagihashi, Satoru Todo, John J. Fung, Thomas E. Starzl - 1991 被引用: 164

  23. Involvement of Macrophage Migration Inhibitory Factor (MIF) in the Mechanism of Tumor Cell Growth

    著者: Norihiko Takahashi, Jun Nishihira, Yuji Sato, Masao Kondo, Hideaki Ogawa, Takahiro Ohshima, Yoshie Une, Satoru Todo - Molecular Medicine 1998 被引用: 160

  24. Treatment of hepatic epithelioid hemangioendothelioma with liver transplantation

    著者: Ignazio R. Marino, Satoru Todo, Mddreas G. Tzakis, Göran B. Klintmalm, Michael Kelleher, S Iwatsuki, Thomas E. Starzl, Carlos O. Esquivel - Cancer 1988 被引用: 136